Status:
TERMINATED
Does Vitamin D Reduce Risk of Developing Type II DM in High Risk Individuals
Lead Sponsor:
King Faisal Specialist Hospital & Research Center
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-60 years
Phase:
PHASE3
Brief Summary
Both vitamin D deficiency and type II DM/prediabetes are highly prevalent. Vitamin D status has been negatively associated with the presence of type II DM and glycemic control. A cause-effect relation...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Adults living in Riyadh area with impaired fasting glucose or/and impaired glucose tolerance (prediabetics) and total 25 OH vitamin D level between 10-30 nmol/l
- Who consume no more than one serving of milk/day
- Do not take vitamin supplement
- Habitually have less than 10 hour of sun exposure per week
- Don't suffer from granulomatus conditions, liver disease, kidney disease, or diabetes
- Don't take anticonvulsants, barbiturates, steroids, or antidiabetic medications.
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2014
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01170468
Start Date
December 1 2011
End Date
January 15 2014
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Faisal Specialist Hospital & Research Center
Riyadh, Saudi Arabia, 11211